Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS

IOS Provides Automated CompoundingQMS to Assist Canadian Pharmacies Reach NAPRA Compliance


TORONTO, June 12, 2018 (GLOBE NEWSWIRE) -- Innovative OncoSolutions Inc. (IOS) announced today a fully compliant NAPRA quality management system for the Canadian pharmacy compounding market. "CompoundingQMS is the first quality management system that includes all the NAPRA/797/ 800 Model Standards for pharmacy compounding of non-hazardous and hazardous sterile preparations," said Cathy Bratt-Rico, President of IOS. "We are partnering with Pharmacy Stars, the leader in compliance automated solutions, and with Visante Canada, the premier medication management consulting company for SOP content. By using CompoundingQMS, customers will be guided through all elements required for NAPRA compliance with the most flexible, automated system available. More importantly, NAPRA guidelines will ensure a safer environment and pharmacies can save significant time by using this system."

"CompoundingQMS is the first and most customizable cloud-based solution incorporating best practices that address the multiple quality, safety and compliance challenges of pharmacies," added Keith Streckenbach, CEO Pharmacy Stars. "It replaces inefficient paper & spreadsheet compliance programs and less customizable web-based tools. Pharmacies are amazed at how quickly and easily they can move to a fully automated solution and are audit-ready at any time."

"IOS has a deep and close business relationship with Visante," said James Jorgenson, CEO Visante Canada. IOS is able to bring the experience of Visante's global pharmacy experts in USP 795, 797, 800, 825, cGMP and NAPRA together to support any compliance issues related to these standards. Our SOPs are inclusive of NAPRA model standards for personnel, policies and procedures, facilities and equipment and maintenance. As a leader in pharmacy practice, we ensure all updates and revisions are regularly included moving forward."

"Implementation is easy and straightforward," added Cathy Bratt-Rico. "Pharmacies can implement and begin using CompoundingQMS in less than a week. There is no IT integration or support required. We have found the system to be extremely cost-effective for both single and multi-site users."

Innovative OncoSolutions (IOS), is a privately held Canadian company based in Toronto since 2014. IOS markets and distributes premier pharmacy/oncology tools to the Canadian marketplace. For a complete description of IOS tools and services visit www.oncosolutions.ca


These press releases may also interest you

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....

at 03:00
CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who...



News published on and distributed by: